alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - [Docket No. FDA-2018-N-2727]

# AGENCY:

Food and Drug Administration, HHS.

# ACTION:

Notice.

# SUMMARY:

                        The Food and Drug Administration (FDA or Agency) is announcing that a collection of information entitled “Institutional                               ( print page 3409)                            Review Board Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.                    

# FOR FURTHER INFORMATION CONTACT:

                        Domini Bean, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-5733,                         *PRAStaff@fda.hhs.gov.*

# SUPPLEMENTARY INFORMATION:

                    On November 27, 2023, the Agency submitted a proposed collection of information entitled “Institutional Review Board Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations” to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0130. The approval expires on December 31, 2026. A copy of the supporting statement for this information collection is available on the internet at                     *https://www.reginfo.gov/​public/​do/​PRAMain.*

Dated: January 12, 2024.

Lauren K. Roth,

Associate Commissioner for Policy.

[FR Doc. 2024-00886 Filed 1-17-24; 8:45 am]

BILLING CODE 4164-01-P
EXHIBIT32.1





CERTIFICATION PURSUANT TO RULE 13a-14(b) OR


RULE 15d-14(b) and 18 U.S.C. §1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002








In connection with the quarterly report of Spur Ranch, Inc. (the "Company") on Form 10-Q for the quarter ended September 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, W. Andrew Stack, Chief Executive Officer and Principal Executive Officer of the Company, certify,  pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;


and





(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.







Date: November 22, 2010
By:
/s/  W. Andrew StackW. Andrew StackChief Executive Officer(Principal Executive Officer)
----

----

|   | (1) | the Company’s Quarterly Report on Form 10-Q for the period ended April 3, 2011 fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------|

|                           | APPLETON PAPERS INC. |
|--------------------------------|----------------------|
|                           |                 |   |
| Dated:  May 12, 2011 |                 |   /s/ Mark R. Richards |
|                           | Name:                | Mark R. Richards |
|                           | Title:               | Chairman, President and Chief Executive Officer |
[Federal Register Volume 89, Number 20 (Tuesday, January 30, 2024)]
[Notices]
[Page 5917]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01777]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Board of 
Scientific Counselors, National Cancer Institute, March 04, 2024, 11:00 
a.m. to March 05, 2024, 01:30 p.m., National Cancer Institute, 9609 
Medical Center Drive, Rockville, MD, 20892 which was published in the 
Federal Register on October 30, 2023, FR Doc 2023-23881, 88 FR 74198.
    This notice is being amended to change the meeting start and end 
times on March 4-5, 2024. On March 4, 2024, the open session will now 
be held from 10:00 a.m. to 10:45 a.m. and the closed session will now 
be held from 11:00 a.m. to 4:10 p.m. On March 5, 2024, the closed 
session will now be held from 10:00 a.m. to 12:30 p.m. The meeting will 
be held as a virtual meeting and is partially closed to the public.

    Dated: January 24, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-01777 Filed 1-29-24; 8:45 am]
BILLING CODE 4140-01-P
EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

In connection with the Annual Report of ICT Group, Inc. (the Company) on Form 10-K for the period ended December 31,
2008, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, John J. Brennan, Chairman, President and Chief Executive Officer of the Company, hereby certify, to the best of my knowledge, pursuant to 18
U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|               |  |  |  |                                                
|-------------- |  |  |  | -----------------------------------------------
|               |  | 
|March 13, 2009 |  |  |  | /s/    JOHN J.
BRENNAN                         
|               |  |  |  | John J. Brennan                                
|               |  |  |  | Chairman, President and Chief Executive Officer
GREENWICH CAPITAL


February 11, 2002




Mr. Greg Sullivan
Chief Executive Officer
Ugly Duckling Corporation
4020 East Indian School Road
Phoenix. AZ 85018

Dear Greg:

By execution of this letter and upon receipt of a $10,000 waiver fee,  Greenwich
Capital  Financial  Products,  Inc.  ("Greenwich")  hereby  grants Ugly Duckling
Corporation  and its  related  subsidiaries  a Waiver of the  Cashflow  Interest
Coverage  Ratio,  the Debt to EBITDA Ratio and the Gross Margin  Ratio,  each as
contained  in Section  7.15 of the Ugly  Duckling  Corporation  Master  Loan and
Security Agreement dated April 13. 2001 (the "Agreement"), for the quarter ended
December 3], 200].

Except as expressly amended hereby, the Agreement shall remain in full force and
effect  in  accordance  with  its  terms,  without  any  waiver,   amendment  or
modification of any provision thereof.

Sincerely.

GREENWICH CAPITAL FINANCIAL PRODUCTS. INC.




Iraa J. Platt
Senior Vice President













Greenwich Capital Markets, inc. 600 Steamboat Road G,eenw4ch,  Connecticut 06830
Telephone: (203) 62S-2700
EXHIBIT
32





CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002





In
connection with the quarterly report of microHelix, Inc. (the "Company") on Form
10-Q for the quarterly period ended September 30, 2008 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, James
E. Horswill, President and Chief Financial Officer of the Company, certify
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:





1.
            The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and





2.
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.





Date:  March
24, 2009




/s/
      James E. HorswillJames
      E. HorswillPresident
      and Chief Financial Officer
#### Dorris WAHL, Appellant, v. COMMONWEALTH of Kentucky, Appellee.

Court of Appeals of Kentucky.

Nov. 26, 1965.

Dorris Wahl, pro se.

Robert Matthews, Atty. Gen., Walter C. Herdman, Asst. Atty. Gen., for appellee.

MOREMEN, Chief Justice.

The appellant, Dorris Wahl, was convicted of grand larceny and sentenced to three *775years in prison. He did not appeal his conviction directly hut later moved to vacate the judgment under RCr 11.42. After a hearing the circuit court entered judgment denying the motion. Appellant seeks reversal of the circuit court’s judgment.

The motion alleges the following grounds: (1) That appellant was arrested without a warrant; (2) that evidence introduced against him at the trial was obtained as a result of an illegal search and seizure; (3) that the preliminary hearing was delayed unnecessarily; and (4) that his trial counsel did not represent him adequately.

We have said that the moving party on a motion under RCr 11.42 undertakes a heavy burden to overcome the regularity of the conviction. The motion is not a substitute for appeal, and it does not permit a review of all the alleged errors surrounding the trial. It is applicable only in cases where the judgment is so manifestly wrong as to be void or is otherwise subject to collateral attack.

The appellant has not alleged sufficient grounds for relief under RCr 11.42. His first allegation, that he was illegally arrested, and his second allegation, that illegally seized evidence was used to convict him, may not be raised in proceedings under RCr 11.42. The appellant challenged the legality of the search and seizure at the trial and is not in a position to raise the same question in an RCr 11.42 proceeding at this time. King v. Commonwealth, Ky., 387 S.W.2d 582. The Kentucky criminal procedure provides a remedy to correct such errors by direct appeal. See RCr 12.52. The appellant did not avail himself of this remedy because no direct appeal was taken.

The third alleged error, that the preliminary hearing was delayed unnecessarily, is not sufficient to cause the setting aside of the judgment. The record discloses that there was a period of fourteen days between the time of appellant’s arrest and the time the preliminary hearing was set in police court. The hearing was continued for another eight days apparently because of difficulties encountered in getting the stolen property over the Indiana state line. We find no evidence in the record that this delay prejudiced the appellant in any way.

Appellant also contends that his court-appointed counsel did not represent him adequately. In order to vacate the judgment because of poor representation of counsel, we must find that the circumstances of the representation were such as to shock the conscience of the court and to render the proceedings a farce and a mockery of justice. Rice v. Davis, Ky., 366 S.W.2d 153; King v. Commonwealth, Ky., 387 S.W.2d 582. The record does not disclose such circumstances in the present case.

Judgment affirmed.
EXHIBIT 32

     Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

     In connection with the Annual Report on Form 10-K/A for the year ended
December 31, 2003 (the "Report"), by Xybernaut Corporation (the "Registrant"),
the undersigned hereby certifies that, to his knowledge:

     1. The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended, and

     2. The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Registrant.


By: /s/ EDWARD G. NEWMAN
------------------------
Edward G. Newman
Chief Executive Officer and
Chairman of the Board of Directors

April 26, 2004


By: /s/ THOMAS D. DAVIS
-----------------------
Thomas D. Davis
Senior Vice President and
Chief Financial Officer

April 26, 2004


By: /s/ STEVEN A. NEWMAN
------------------------
Steven A. Newman
President, Chief Operating Officer and
Vice Chairman of the Board of Directors

April 26, 2004


A signed original of this written statement required by Section 906 has been
provided to Xybernaut Corporation and will be retained by Xybernaut Corporation,
and furnished to the Securities and Exchange Commission or its staff upon
request.
COURT OF APPEALS OF VIRGINIA

Present: Judges Baker, Elder and Fitzpatrick

JORGE QUANT

v. Record No. 0079-95-4 MEMORANDUM OPINION * PER CURIAM THE SALVATION ARMY, INC. JULY 18, 1995 AND RELIANCE NATIONAL INDEMNITY COMPANY

FROM THE VIRGINIA WORKERS' COMPENSATION COMMISSION (Arturo Hernandez, on brief), for appellant. (Dawn E. Boyce; Trichilo, Bancroft, McGavin, Horvath & Judkins, on brief), for appellees.

Jorge Quant contends that the Workers' Compensation Commission erred in finding that (1) he was able to return to his pre-injury work; and (2) he failed to prove that arthroscopic surgery was reasonable and necessary. Specifically, the claimant argues that the commission erred in accepting the opinions of other doctors over that of his treating orthopedic surgeon, Dr. Mark W. Theiss. Upon reviewing the record and the briefs of the parties, we conclude that this appeal is without merit. Accordingly, we summarily affirm the commission's decision. Rule

5A:27. On appellate review, we must view the evidence in the light most favorable to the prevailing party below. R.G. Moore Bldg. Corp. v. Mullins , 10 Va. App. 211, 212, 390 S.E.2d 788, 788

* Pursuant to Code § 17-116.010 this opinion is not designated for publication.2 (1990). "[I]t is fundamental that a finding of fact made by the Commission is binding and conclusive upon this court on review. A question raised by conflicting medical opinion is a question of

fact." Commonwealth v. Powell , 2 Va. App. 712, 714, 347 S.E.2d 532, 533 (1986). "Medical evidence is not necessarily conclusive, but is subject to the commission's consideration and weighing." Hungerford Mechanical Corp. v. Hobson , 11 Va. App. 675, 677, 401 S.E.2d 213, 214 (1991). While we have stated that the opinion of the treating physician is entitled to great weight, Pilot Freight Carriers,

Inc. v. Reeves , 1 Va. App. 435, 439, 339 S.E.2d 570, 572 (1986), the law does not require that the treating physician's opinion be accepted over that of others. Accordingly, the commission was entitled to accept the opinions of the independent orthopedic surgeons, Drs. Robert O. Gordon and Joseph D. Linehan, over that of the treating orthopedic surgeon, Dr. Theiss, to find that the claimant was capable of returning to his pre-injury work and that surgery was not reasonable or necessary. The commission noted that, "[w]hile we are reluctant to rule against treatment recommended by a treating orthopedic surgeon, we are impressed in this case by the opinions of two physicians who indicate the claimant is exaggerating his symptoms." The commission also based its denial of recovery for the surgery upon the claimant's documented failure to fully cooperate with the independent orthopedic examinations, and upon the lack of3 objective findings indicating a need for surgery at the present time. The opinions of Drs. Gordon and Linehan constitute credible evidence to support the commission's decision. For the reasons stated, we affirm the commission's decision.

Affirmed.
<PAGE>   1
                           DATUM INC. AND SUBSIDIARIES

                                   EXHIBIT 21


                              LIST OF SUBSIDIARIES

<TABLE>
<CAPTION>
                                                             State or Other
                                                             Jurisdiction of
         Name                                                 Incorporation
         ----                                                ---------------
<S>                                                          <C>
         Datum International Sales Corporation                California

         Datum International Incorporated                     California

         Frequency and Time Systems, Inc.                     Delaware

         Austron, Inc.                                        Texas

         Efratom Time & Frequency Products, Inc.              Colorado

         Efratom Electronik GmbH                              Germany
</TABLE>
II

Calendar No. 615

104TH CONGRESS

2D SESSION S. 1875

To designate the United States courthouse in Medford, Oregon, as the ‘‘James

A. Redden Federal Courthouse’’.

IN THE SENATE OF THE UNITED STATES

JUNE 13, 1996

Mr. HATFIELD (for himself and Mr. WYDEN) introduced the following bill;

which was read twice and referred to the Committee on Environment and

Public Works

SEPTEMBER 18, 1996

Reported by Mr. CHAFEE, without amendment

A BILL

To designate the United States courthouse in Medford,

Oregon, as the ‘‘James A. Redden Federal Courthouse’’.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. DESIGNATION.

4 The United States courthouse at 310 West Sixth

5 Street in Medford, Oregon, shall be known and designated

6 as the ‘‘James A. Redden Federal Courthouse’’.
2

S 1875 RS

1 SEC. 2. REFERENCES.

2 Any reference in a law, map, regulation, document,

3 paper, or other record of the United States to the United

4 States courthouse referred to in section 1 shall be deemed

5 to be a reference to the ‘‘James A. Redden Federal Court6 house’’.

Calendar No. 615

104TH CONGRESS

2D SESSION S. 1875

A BILL

To designate the United States courthouse in MedCourthouse’’. ford, Oregon, as the ‘‘James A. Redden Federal

SEPTEMBER 10, 1996

Reported without amendment
PROMISSORY
NOTE


	$2,000	October 4, 2011






FOR GOOD AND VALUABLE CONSIDERATION,
the receipt and sufficiency of which is hereby acknowledged, SOI Nevada, LLC, a Nevada limited liability company, (“Maker”)
hereby promises to pay to the order of Sterling Hamilton (“Holder”) the sum of TWO THOUSAND DOLLARS ($2,000). This
Note shall bear interest at the rate of six percent (6%) per annum. All principal and interest due hereunder shall be paid on or
before October 4, 2013. 


Maker hereby waives presentment,
dishonor, notice of dishonor and protest. All parties hereto consent to, and Holder is expressly authorized to make, without notice,
any and all renewals, extensions, modifications, or waivers of the time for or the terms of payment of any sum or sums due hereunder,
or under any documents or instruments relating to or securing this Note, or of the performance of any covenants, conditions or
agreements hereof or thereof or the taking or release of collateral securing this Note. Any such action by Holder shall not discharge
the liability of any party to this Note.


This Note shall be governed
by and construed in accordance with the laws of the State of Nevada without regard to conflict of law principles. Maker shall also
pay Holder any and all costs of collection incurred in connection with this Note, including court costs and reasonable attorney’s
fees.





SOI Nevada, LLC


By: /s/ Sterling Hamilton


Sterling Hamilton,
Manager
COURT OF APPEALS

EIGHTH DISTRICT OF TEXAS

EL PASO, TEXAS

PRECILE VONN,

 

 Appellant,

v.

THE STATE OF TEXAS,

 State.

§

§

§

§

§

§

§

No. 08-22-00145-CR

Appeal from the

210th District Court

of El Paso County, Texas 

(TC# 20210D01580)

O R D E R

Pending before the Court is a motion filed by Appellants’ attorney, Joshua C. Spencer, to 

withdraw as counsel. The Court has DENIED the motion to withdraw finding good cause has not 

been shown in accordance with Article 26.04 (j)(2). TEX. CODE CRIM. PROC. See Local Rule 

5.04.

IT IS SO ORDERED this 8

thday of September, 2022.

PER CURIAM

Before Rodriguez, C.J., Palafox and Alley, JJ.
EXHIBIT 23.1

CONSENT OF INDEPENDENT AUDITORS

We consent to the incorporation by reference in the Registration Statement (Form
S-8 No. 333-41981)  pertaining to the Travis Boats & Motors, Inc. 1995 Incentive
Plan, the  Registration  Statement  (Form S-3 No.  333-89557)  pertaining to the
registration of 86,005 shares of its common stock,  the  Registration  Statement
(Form S-3 No. 333-46217) pertaining to the registration of 219,875 shares of its
common stock, and the Registration Statement (Form S-3 No. 333-80343) pertaining
to the  registration  of 91,905 shares of its common stock,  of our report dated
November 22,  2002,  except Notes 1,5 and 14, as to which the date is January 7,
2003, with respect to the consolidated  financial statements of Travis Boats and
Motors,  Inc.  included  in the  Annual  Report  (Form  10-K) for the year ended
September 30, 2002.



Austin, Texas
January 15, 2003
**Exhibit 99.1**

 

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

 

**PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTEDPURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

Theundersigned, Ray J. Oleson the Chief Executive Officer of SI International,Inc. (the “Company”), has executed this certification in connection with thefiling with the Securities and Exchange Commission of the Company’s QuarterlyReport on Form 10-Q for the quarter ending March 29, 2003 (the “Report”).  The undersigned hereby certifies that:

 

(1)           the Report fully complies with therequirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;and

 

(2)           the information contained in theReport fairly presents, in all material respects, the financial condition andresults of operations of the Company.

 

 
| Date:  | May 12, 2003                                 |   |                 /s/ Ray J. Oleson |
|--------|----------------------------------------------|--------|--------------------------------------------------------------------------------------------------------------|
|   | Name:  Ray J. Oleson                    |
|   | Title:  Chairman and Chief Executive Officer |

 

----